Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
KALV - As of  05/12/24, 10:51:03 PM:   18 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for KALV

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-04-10 14:01:18.0 KalVista Pharmaceuticals KALV FMR LLC 10.034% view
S 2020-02-14 16:07:48.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 5.7% view
B 2020-02-13 12:45:19.0 KalVista Pharmaceuticals KALV Flynn James E 9.4% view
S 2019-04-18 18:35:52.0 KalVista Pharmaceuticals KALV RA CAPITAL MANAGEMENT 5.6% view
S 2019-04-03 15:27:02.0 KalVista Pharmaceuticals KALV SVLSF IV 11.5% view
B 2018-09-12 16:32:32.0 KalVista Pharmaceuticals KALV Venrock Healthcare Capital Partners II 12.3% view
B 2018-08-09 16:33:24.0 KalVista Pharmaceuticals KALV EVENTIDE ASSET MANAGEMENT 6.6% view
B 2017-11-13 16:31:49.0 KalVista Pharmaceuticals KALV Longwood Fund II 8.7% view
S 2017-10-16 10:59:02.0 KalVista Pharmaceuticals KALV Novo Holdings A 0.0% view
B 2017-09-22 17:21:56.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
B 2017-02-14 16:26:39.0 KalVista Pharmaceuticals CBYL Vivo Ventures VI 16.0% view
B 2017-02-07 14:51:49.0 KalVista Pharmaceuticals CBYL SVLSF IV 26.6% view
S 2016-11-30 16:24:02.0 KalVista Pharmaceuticals CBYL Novo A 1.7% view
S 2016-05-10 08:40:11.0 Carbylan Therapeutics CBYL FMR LLC 7.413% view
B 2016-02-12 12:31:56.0 Carbylan Therapeutics CBYL PRICE T ROWE ASSOCIATES INC 12.784% view
B 2016-02-04 13:40:59.0 Carbylan Therapeutics CBYL FRANKLIN RESOURCES INC 10.7% view
B 2015-05-11 09:16:54.0 Carbylan Therapeutics CBYL FMR LLC 16.6% view
B 2015-04-23 21:12:08.0 Carbylan Therapeutics CBYL InterWest Partners IX 17.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.